Stockscreener 앱 받기
5.833
12.39%
0.643
전일 마감가:
$5.19
열려 있는:
$5.49
하루 거래량:
21,869
Relative Volume:
3.14
시가총액:
$96.78M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+9.61%
1개월 성능:
+0.92%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$5.49
$5.90
1주일 범위
$5.01
$5.90
52주 변동 폭
$4.7237
$6.85
Bioharvest Sciences Inc Stock (BHST) Company Profile
BHST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
5.85 | 96.78M | 0 | 0 | 0 | 0.00 |
|
KHC
Kraft Heinz Co
|
30.25 | 36.98B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
59.65 | 33.00B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova
|
82.27 | 28.11B | 12.75B | 1.34B | 1.13B | 3.87 |
|
MKC
Mccormick Co Inc
|
80.53 | 21.49B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.55 | 16.31B | 11.92B | 805.04M | 1.01B | 1.46 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Maxim Group | Buy |
Bioharvest Sciences Inc 주식(BHST)의 최신 뉴스
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025 - Newsfile
BioHarvest Sciences achieves breakthrough in Liver health with Olive Cell compound - Proactive Investors USA
BioHarvest’s Olive Cell Compound Shows Promise in Tackling Liver Fat Accumulation - TipRanks
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells - Newsfile
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells - Benzinga
BioHarvest Sciences Inc. (NASDAQ:BHST) Not Flying Under The Radar - Simply Wall St
BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit - Yahoo Finance
BioHarvest Sciences surpasses 50 million dollars in VINIA sales, plans major production expansion - Proactive Investors USA
BioHarvest's VINIA sales top $50M, plans production boost By Investing.com - Investing.com Canada
BioHarvest’s VINIA Achieves $50 Million in Sales, Plans Major Expansion - TipRanks
BioHarvest's VINIA sales top $50M, plans production boost - Investing.com India
BioHarvest’s VINIA sales top $50M, plans production boost - Investing.com
BioHarvest’s VINIA sales top $50M, plans production boost By Investing.com - Investing.com Nigeria
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD - Newsfile
BioHarvest Sciences to Delist from CSE, Focuses on Nasdaq - TipRanks
CSE Bulletin: DelistBioHarvest Sciences Inc. (BHSC) - TradingView
BioHarvest CEO to present at WeBull Consumer Stocks Virtual Webinar - Proactive Investors USA
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar - TipRanks
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18 - Newsfile
Exclusive: Inside BioHarvest's Revolutionary Plant-Based TechnologyCEO Reveals Growth Strategy - StockTitan
Bioharvest Sciences to voluntarily delist from CSE - Proactive Investors Australia
BioHarvest Sciences to Delist from CSE, Focus on Nasdaq - TipRanks
When Will BioHarvest Sciences Inc. (CSE:BHSC) Become Profitable? - Simply Wall St
BioHarvest Sciences reports material change - Investing.com India
BioHarvest Sciences Appoints Sharon Malka to Board of Directors - TipRanks
BioHarvest Sciences reports material change By Investing.com - Investing.com UK
BioHarvest Sciences appoints veteran technology leader to board of directors - Proactive Investors UK
BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile
Bioharvest Sciences Inc. Appoints Sharon Malka as Independent Director -January 22, 2025 at 08:34 am EST - Marketscreener.com
OTC Markets Group Announces Quarterly Index Performance and Rebalancing - GlobeNewswire Inc.
BioHarvest Sciences positioned for ‘legacy year’ in 2025, building on momentum with new innovations and strategic collaborations - Proactive Investors UK
BioHarvest Sciences doubles VINIA business, eyes growth By Investing.com - Investing.com Australia
CSE Bulletin: NV Issuer DesignationBioHarvest Sciences Inc. (BHSC) - Newsfile
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth - Proactive Investors UK
BioHarvest Sciences Unveils Strategic Growth Initiatives with New CDMO Division - TipRanks
BioHarvest Sciences doubles VINIA business, eyes growth - Investing.com
BioHarvest Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
BioHarvest Sciences (NASDAQ:BHST) Earns Buy Rating from Analysts at Maxim Group - Defense World
Maxim Group sets Buy rating on BioHarvest Sciences shares, cites robust growth - Investing.com India
Bioharvest Sciences Inc (BHST) 재무 분석
Bioharvest Sciences Inc (BHST)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.39%
0.20%
자본화:
|
볼륨(24시간):